Skip to content
OpenCapital
Get started

AIM ImmunoTech AIM Q2 2025 earnings

Reported August 14, 2025 · Before market open

Revenue$25.0KMiss by $75.0KDiluted EPS-$3.68Beat by $4.32
Revenue estimate$100.0K
EPS estimate-$8.00

Next report

Aug 13, 2026 (in a month)
Revenue estimate$100.0K
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$22.0KBeat by $11.0KQ4 2025$21.0KMiss by $79.0KQ3 2025$26.0K
Q2 2025$25.0KMiss by $75.0K
Q1 2025$16.0KQ4 2024$45.0KMiss by $55.0K

Diluted EPS

Q1 2026-$0.69Beat by $0.39Q4 2025-$0.44Beat by $0.50Q3 2025-$1.57Miss by $0.59
Q2 2025-$3.68Beat by $4.32
Q1 2025-$5.00Beat by $3.00Q4 2024-$10.00Miss by $1.00

Ask the moment AIM ImmunoTech reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AIM ImmunoTech report Q2 2025 earnings?
AIM ImmunoTech (AIM) reported Q2 2025 earnings on August 14, 2025 before market open.
What were AIM ImmunoTech's Q2 2025 revenue and EPS?
AIM ImmunoTech reported revenue of $25.0K and diluted EPS of $-3.68 for Q2 2025.
Did AIM ImmunoTech beat estimates in Q2 2025?
Revenue missed the consensus estimate of $100.0K by $75.0K. EPS beat the consensus estimate of $-8.00 by $4.32.
How did AIM ImmunoTech's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 50.0% from $50.0K a year earlier and diluted EPS declined 22.7% from $-3.00.
Where can I find AIM ImmunoTech's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001493152-25-011986) directly on SEC EDGAR. The filing index links above go to sec.gov.